PIK3CA and breast carcinoma: Next, two MGPs, “phosphoenolpyruvate-PIK3CA-glycolysis/gluconeogenesis” and “fumarate-PIK3CA-citric acid cycle,” were predicted for Breast-AdenoCA, and may provide hypotheses for overcoming trastuzumab resistance in breast cancer with PIK3CA mutation [51].